SCHEMBL4500826

SCHEMBL4500826

Cc1ccc2oc(-c3cc(Br)ccc3F)nc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.54
ALDH1A1 P00352 9/20 0.54
HPGD P15428 8/20 0.54
RAB9A P51151 8/20 0.54
SMN1; SMN2 Q16637 7/20 0.54
NPC1 O15118 7/20 0.54
HSD17B10 Q99714 5/20 0.54
TP53 P04637 3/20 0.54
CASP3 P42574 4/20 0.51
SENP7 Q9BQF6 4/20 0.51
SENP6 Q9GZR1 4/20 0.51
SENP8 Q96LD8 3/20 0.51
POLB P06746 1/20 0.51
MAPT P10636 6/20 0.50
XBP1 P17861 1/20 0.50
HIF1A Q16665 1/20 0.50
GAA P10253 1/20 0.49
NFKB1 P19838 4/20 0.47
NFKB2 Q00653 4/20 0.47
RELA Q04206 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3136773 0.83 KDM4E (0.54) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL7258748 0.83 RAB9A (0.67) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL3142243 0.81 KDM4E (0.55) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL5834798 0.78 MMP2 (0.67) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL4502713 0.78 ALOX5 (0.49) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL22103734 0.78 NPC1 (0.81) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL14699734 0.76 KDM4E (0.68) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL5834676 0.76 RAB9A (0.53) ALDH1A1RAB9ASMN1; SMN2NPC1POLB
SCHEMBL28331588 0.75 SMN1; SMN2 (0.69) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL4544482 0.75 KDM4E (0.54) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090258917-A1 Benzoxazoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-10-15 US disclosed
EP-1933834-A1 BENZOXAZOLES USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2008-06-25 EP disclosed
WO-2007042816-A1 BENZOXAZOLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2007-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258917-A1 Benzoxazoles Useful in the Treatment of Inflammation IL4I1, EPX, IL4 KDM4E 1264/4885ALDH1A1 1647/4885HPGD 411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.